PRESS RELEASE: Exploiting the oncogenic drivers of the CCNG1 pathway

DeltaRex-G generates significant interest in a Commentary published in Molecular Therapy Family of Journals, the Official Organ of the American Society of Gene and Cell Therapy (ASGCT).

Jackie Pancari (11 year breast cancer survivor)

Thank you so much for your kind words. I am so glad you enjoyed the video. It feels good to be working again, my bones are stronger. Honestly, I never thought I would blow glass again.

And, I want you to know how grateful and thankful I am to have had the opportunity to use rexin-g and reximmune-C. I know without a doubt that these drugs have contributed to my longevity.

Thank you so much,

kindest regards,
jackie

Letter from MF's nurse (MF, 10 year osteosarcoma survivor)

Hi Dr Gordon,

Visited Mond this afternoon. He was very happy to see me. Told the family about Fr Aveni's ongoing Beatification. Mond is very willing to write his good experience with Rexin-g [sic]. He is no longer taking any medicines. He still has PEG for feeding. But he can still swallow liguids very well. He loves soup and coffee. He was 23 years old when he started Rexin -G treatment. Now he is 34 years old, energetic and happy.

Best regards,
Vangie
Evangeline C. Penas, RN

Confirmation of Long-term Survivors (Dr. Jorge Ignacio)

I confirm that RL and MF  are still alive over 9 years after Rexin-G treatment on no further cancer therapy.

Dr. Ignacio

Appreciation and Gratitude (Letter from Fr. Jessie Martirizar)

Dearest everyone behind the Aveni Foundation,

I would like to express my deepest appreciation and gratitude for the wonderful things you have been doing in honour of our beloved Fr. Joseph Aveni, especially with the establishment of this Foundation under his name. It goes without saying that Fr. Aveni will intercede for this noble initiative in favour of needy cancer patients. On my part I can assure you of my constant prayers so that the good Lord will bless this noble endeavour.